- Home
- ALRM vs MRUS Comparison
ALRM vs MRUS Comparison
Compare ALRM & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRM
- MRUS
- Stock Information
- Founded
- ALRM 2000
- MRUS 2003
- Country
- ALRM United States
- MRUS Netherlands
- Employees
- ALRM N/A
- MRUS N/A
- Industry
- ALRM Computer Software: Prepackaged Software
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- ALRM Technology
- MRUS Health Care
- Exchange
- ALRM Nasdaq
- MRUS Nasdaq
- Market Cap
- ALRM 2.7B
- MRUS 2.9B
- IPO Year
- ALRM 2015
- MRUS 2016
- Fundamental
- Price
- ALRM $68.46
- MRUS $44.16
- Analyst Decision
- ALRM Buy
- MRUS Strong Buy
- Analyst Count
- ALRM 6
- MRUS 12
- Target Price
- ALRM $65.33
- MRUS $87.92
- AVG Volume (30 Days)
- ALRM 400.5K
- MRUS 635.1K
- Earning Date
- ALRM 11-07-2024
- MRUS 10-31-2024
- Dividend Yield
- ALRM N/A
- MRUS N/A
- EPS Growth
- ALRM 80.16
- MRUS N/A
- EPS
- ALRM 2.31
- MRUS N/A
- Revenue
- ALRM $923,824,000.00
- MRUS $35,932,000.00
- Revenue This Year
- ALRM $8.17
- MRUS N/A
- Revenue Next Year
- ALRM $4.58
- MRUS $57.37
- P/E Ratio
- ALRM $29.14
- MRUS N/A
- Revenue Growth
- ALRM 6.98
- MRUS N/A
- 52 Week Low
- ALRM $51.87
- MRUS $24.95
- 52 Week High
- ALRM $77.29
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- ALRM 69.31
- MRUS 43.33
- Support Level
- ALRM $66.70
- MRUS $41.03
- Resistance Level
- ALRM $68.00
- MRUS $43.68
- Average True Range (ATR)
- ALRM 1.40
- MRUS 2.28
- MACD
- ALRM -0.20
- MRUS 0.14
- Stochastic Oscillator
- ALRM 71.49
- MRUS 29.61
About ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices. SaaS & license fees from service providers, who resell these services & pay Alarm.com a monthly subscription, are the sources of revenue for the firm. The majority of revenue is generated in the United States & Canada.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.